Research Interests
Open to PhD applications in the field of nano-drug delivery, biopharmaceutics, nucleic acid therapies and ex vivo cellular therapies.
- Development of nanomedicines for cancer and neurological diseases
- Design of non-viral delivery systems
- Delivery of nucleic acids (mRNA, siRNA, ASOs, etc)
Current Research Opportunities
- Non-invasive intranasal delivery of nucleic acid therapeutics for retinal disease using a novel peptide carrier
- Formulation of hybrid peptide-lipid nanoparticle formulations for targeted nucleic acid delivery
- Intranasal delivery of nucleic acid therapeutics for neurodegenerative diseases using a novel peptide carrier
- In vivo CAR-T engineering using targeted peptide delivery systems
- In vivo CAR-T engineering using targeted peptide delivery systems for treatment of acute lymphoblastic leukaemia (ALL)
Public outreach & key achievements
Recent articles:
Research students
| PhD Title | Non-viral Genetic Engineering of Immune Effector Cells for CAR therapies |
| Name | Ciaran McGranaghan |
| Years of Study | 2024 - 2027 |
| Country | Northern Ireland |
| PhD Title | Non-viral genetic engineering of immune cells for CAR therapies |
| Name | Zixu Liu |
| Years of Study | 2025 - 2028 |
| Country | China |